Cardio Round-up: Cardio Tech News; Naps and Stroke, and Whither Aspirin?

4 Cardio-Tech News Bits

This batch of cardiology tech-related news articles features a peek at remote-controlled ‘smart’ platform aids for cardiovascular disease treatment; artificial neurons for treatment of various chronic illnesses; and the use of AI to find signs of heart disease in lung cancer CT scans. The final story shows how an internet-based therapy program was associated with improvements in depression symptoms in patients with cardiovascular disease.

The Intersection of Digital Tech and Cardiology: 4 News Items

Should Aspirin Still Be Recommended for Primary Prevention?

A new analysis concluded that aspirin may not be an effective prevention strategy for cardiovascular disease and cancer. “Per 1,200 persons taking aspirin for primary prevention for five years, there will be four fewer major adverse cardiovascular events, three fewer ischemic strokes, three more intracranial hemorrhages and eight more major bleeding events,” the study authors said. “Aspirin should no longer be recommended for primary prevention.”

Aspirin No Longer Recommended for Primary Cardiovascular Prevention

Does Taking Longer Naps Increase Stroke Risk?

New research published in Neurology suggests that napping for 90 minutes or more during the day, coupled with more than nine hours per night of sleep, were associated with increases in the risk for stroke. “More research is needed to understand how taking long naps and sleeping longer hours at night may be tied to an increased risk of stroke, but previous studies have shown that long nappers and sleepers have unfavorable changes in their cholesterol levels and increased waist circumferences, both of which are risk factors for stroke,” author Xiaomin Zhang, MD, PhD, of Huazhong University of Science and Technology in Wuhan, China, wrote of the study.